Global Health Limited

Global Health Limited

GLH.AX
Global Health LimitedAU flagAustralian Securities Exchange
0.06
AUD
+0.00
- -
3.41MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Revenue per Share
0.21
0.16
0.14
0.12
0.17
0.13
0.15
0.16
0.15
0.17
0.12
0.14
0.14
Basic EPS, GAAP
-0.03
0.04
0.04
0.03
0.04
0.06
-0.01
-0.04
- -
-0.01
-0.04
-0.14
-0.02
Free Cash Flow per Basic Share
-0.04
0.02
0.01
-0.02
-0.03
0.06
-0.06
-0.03
-0.02
-0.02
-0.02
-0.02
- -
Dividend per Share
- -
- -
- -
- -
- -
0.02
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.02
0.04
0.08
0.11
0.15
0.14
0.13
-0.02
- -
0.05
0.07
-0.06
-0.05
Tangible Book Value per Share
-0.09
-0.03
-0.01
-0.01
- -
0.01
-0.06
-0.14
-0.09
- -
0.05
-0.03
-0.05
Basic Weighted Avg Shares
20
28
34
34
34
35
35
35
39
42
56
58
58
Sales/Revenue/Turnover
4
4
5
4
6
5
5
5
6
7
7
8
8
Operating Margin (%)
-16.95
22.22
20.11
9.68
13.1
-58.53
-19.23
-16.13
-7
-0.16
-30.23
-47.7
-21.68
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
Net Income, GAAP
-1
1
1
1
1
2
- -
-1
- -
- -
-2
-8
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-16.09
24.39
30.27
26.81
23.91
41.94
-4.98
-22.79
-1.01
-7.06
-31.35
-103.02
-16.15
Working Capital
-2
-2
-1
-1
1
3
- -
-4
-3
1
2
-2
-2
LT Debt
- -
- -
- -
- -
1
1
1
1
- -
- -
- -
- -
1
Total Equity
- -
1
3
4
5
5
5
-1
- -
3
6
-2
-3
Return on Invested Capital (%)
- -
128.14
48.21
11.93
14.34
-40.45
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
207.38
77.74
35.06
28.37
31.58
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
75.79
33.58
31.14
38.29
-5.53
- -
- -
- -
-67.82
- -
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
92.99%
195.23%
79.05%
Free Cash Flow
-85.01%
-21.45%
-98.04%
Net Income, GAAP
145.66%
230.52%
-83.71%
Sales/Revenue/Turnover
7%
8.66%
3.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
7
2023
- -
- -
- -
- -
8
2024
- -
- -
- -
- -
8

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.04
2023
- -
- -
- -
- -
-0.14
2024
- -
- -
- -
- -
-0.02

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Alumootil Mathew Ravi Cherian
Full Time Employees
49
Sector
Healthcare
Industry
Medical - Care Facilities
Address
696 Bourke Street Melbourne VIC Australia 3000
IPO Date
Apr 3, 2000
Business
Global Health Limited is a leading provider of digital health software solutions focused on community health and human services, including drug and alcohol treatment, disability, dental care, post-acute and community care, mental health services, and rehabilitation. The company offers a comprehensive portfolio of products such as the MasterCare suite, which integrates clinical and administrative modules to digitalize provider organizations' workflows and enable AI-driven clinical decision support; ReferralNet, a secure messaging platform that facilitates encrypted sharing of sensitive patient data among healthcare providers; and LifeCard, a patient-centered personal health record app designed to enhance chronic condition management and consumer engagement. Global Health also serves hospitals and allied health professionals with software for practice management, patient intake, appointments, and comprehensive clinical records, extending its solutions to pharmacy and remote healthcare delivery. Founded in 2004 and headquartered in New Delhi, India, Global Health operates primarily in the Indian healthcare market and has expanded significantly in recent years. Recent major developments include the acquisition of medical software and associated assets of Abaki Pty Ltd, which added over 400 clients and expanded the company’s reach into general practice, allied health, specialists, day hospitals, pathology, and radiology segments. This acquisition broadened Global Health’s product range with offerings like Practice 2000 (a medical business administration platform), MediNet (an electronic medical record system), PracLab (a laboratory information system), and Day Surgery Reporting modules. The company also secured a $1 million contract with Youturn to enhance youth mental health digital solutions and has made strategic land acquisitions for hospital expansion, such as a 3.5-acre site in Guwahati, Assam, reflecting its commitment to expanding healthcare infrastructure. Global Health is publicly traded on the Australian Securities Exchange under the ticker GLH.AX and continues to invest in sales expansion and research and development, positioning itself for growth through organic initiatives and mergers and acquisitions in the digital healthcare space.